355 related articles for article (PubMed ID: 25644715)
21. Lymphoepithelial-like carcinoma of the oropharynx: a morphologic variant of HPV-related head and neck carcinoma.
Singhi AD; Stelow EB; Mills SE; Westra WH
Am J Surg Pathol; 2010 Jun; 34(6):800-5. PubMed ID: 20421782
[TBL] [Abstract][Full Text] [Related]
22. Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma: A comprehensive update.
Devaraja K; Aggarwal S; Verma SS; Gupta SC
Life Sci; 2020 Mar; 245():117383. PubMed ID: 32007572
[TBL] [Abstract][Full Text] [Related]
23. Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients.
Mazurek AM; Rutkowski T; Fiszer-Kierzkowska A; Małusecka E; Składowski K
Oral Oncol; 2016 Mar; 54():36-41. PubMed ID: 26786940
[TBL] [Abstract][Full Text] [Related]
24. Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival.
Wittekindt C; Gültekin E; Weissenborn SJ; Dienes HP; Pfister HJ; Klussmann JP
Adv Otorhinolaryngol; 2005; 62():72-80. PubMed ID: 15608419
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiles in HPV-infected head and neck cancer.
Schlecht NF; Burk RD; Adrien L; Dunne A; Kawachi N; Sarta C; Chen Q; Brandwein-Gensler M; Prystowsky MB; Childs G; Smith RV; Belbin TJ
J Pathol; 2007 Nov; 213(3):283-93. PubMed ID: 17893858
[TBL] [Abstract][Full Text] [Related]
26. Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model.
Strati K; Pitot HC; Lambert PF
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14152-7. PubMed ID: 16959885
[TBL] [Abstract][Full Text] [Related]
27. p16INKa immunocytochemistry in fine-needle aspiration cytology smears of metastatic head and neck squamous cell carcinoma.
Grimes R; Garcia-Buitrago MT; Jorda M; Ganjei-Azar P; Ferrell A; Gomez-Fernandez C
Acta Cytol; 2013; 57(1):33-7. PubMed ID: 23221169
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications.
Chung CH; Gillison ML
Clin Cancer Res; 2009 Nov; 15(22):6758-62. PubMed ID: 19861444
[TBL] [Abstract][Full Text] [Related]
29. Detection of active human papilloma virus-16 in head and neck cancers of Asian North Indian patients.
Sannigrahi MK; Singh V; Sharma R; Panda NK; Radotra BD; Khullar M
Oral Dis; 2016 Jan; 22(1):62-8. PubMed ID: 26475514
[TBL] [Abstract][Full Text] [Related]
30. Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma.
Deng Z; Hasegawa M; Kiyuna A; Matayoshi S; Uehara T; Agena S; Yamashita Y; Ogawa K; Maeda H; Suzuki M
Head Neck; 2013 Jun; 35(6):800-8. PubMed ID: 22791649
[TBL] [Abstract][Full Text] [Related]
31. Advances in human papillomavirus detection and molecular understanding in head and neck cancers: Implications for clinical management.
Tran NH; Sais D; Tran N
J Med Virol; 2024 Jun; 96(6):e29746. PubMed ID: 38884391
[TBL] [Abstract][Full Text] [Related]
32. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience.
Singhi AD; Westra WH
Cancer; 2010 May; 116(9):2166-73. PubMed ID: 20186832
[TBL] [Abstract][Full Text] [Related]
33. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus and oropharynx cancer: biology, detection and clinical implications.
Allen CT; Lewis JS; El-Mofty SK; Haughey BH; Nussenbaum B
Laryngoscope; 2010 Sep; 120(9):1756-72. PubMed ID: 20669304
[TBL] [Abstract][Full Text] [Related]
35. Viral interaction: a possible contributing factor in head and neck cancer progression.
Underbrink MP; Hoskins SL; Pou AM; Albrecht T
Acta Otolaryngol; 2008; 128(12):1361-9. PubMed ID: 18607925
[TBL] [Abstract][Full Text] [Related]
36. P16INK4a expression, human papillomavirus, and survival in head and neck cancer.
Smith EM; Wang D; Kim Y; Rubenstein LM; Lee JH; Haugen TH; Turek LP
Oral Oncol; 2008 Feb; 44(2):133-42. PubMed ID: 17360226
[TBL] [Abstract][Full Text] [Related]
37. The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases.
Doxtader EE; Katzenstein AL
Hum Pathol; 2012 Mar; 43(3):327-32. PubMed ID: 21840041
[TBL] [Abstract][Full Text] [Related]
38. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma.
Ressler S; Scheiden R; Dreier K; Laich A; Müller-Holzner E; Pircher H; Morandell D; Stein I; Viertler HP; Santer FR; Widschwendter A; Even J; Jansen-Dürr P; Capesius C; Zwerschke W
Clin Cancer Res; 2007 Dec; 13(23):7067-72. PubMed ID: 18056184
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Aderhold C; Umbreit C; Faber A; Sauter A; Sommer JU; Birk R; Erben P; Hofheinz RD; Stern-Straeter J; Hörmann K; Schultz JD
Anticancer Res; 2013 May; 33(5):1951-61. PubMed ID: 23645743
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus type 16 in head and neck carcinogenesis.
Chen R; Aaltonen LM; Vaheri A
Rev Med Virol; 2005; 15(6):351-63. PubMed ID: 15942978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]